dihexa cancer risk hgf c met The HGF/c-Met Axis: A Promising Therapeutic Target in c-Met Signaling as a Therapeutic
c Met Signaling as a Therapeutic Target in Head : The Cancer Journal Recent Progress and Advances in HGF MET Targeted Therapeutic Agents for Cancer Treatment Anti cancer therapeutic strategies based on HGF MET, EpCAM, and tumor stromal cross talk Cancer Cell International Springer Nature Link dihexa c met cancer risk Developing pathway inhibitors for therapy: progress and challenges: Trends in Molecular Medicine Activated HGF c Met Axis in Head Targeting HGF c MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion Cell Communication and Signaling Springer Nature Link Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress
Pay in 4 interest-free payments of $5.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




